Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
US FDA Observation
|
Mid-range Performer
349.4000
-4.05
(
-1.15
%)
NSE
Oct 13, 2025
15:31 PM
Volume:
833.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
13 Nov 2023, 12:00AM
US FDA Observation
349.40
-1.15%
Result Update:Biocon
Hold:
Biocon Ltd.
by
Axis Direct
Target: 250
Target
Axis Direct
We have maintained a Hold on stock.
Institutional Investors have increased holdings from 21.40% to 28.87% in Jun 2025 qtr.
More from Biocon Ltd.
Recommended
Market closes lower, L&T bags power orders worth over Rs 2,500 crore
Trendlyne Marketwatch |
13 Oct 2025, 04:02PM
IPO market cools: LG Electronics, Canara Robeco, plus seven listings, and a new issue
|
13 Oct 2025, 04:01PM
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020